Human Natural Killer Cells Prevent Infectious Mononucleosis Features by Targeting Lytic Epstein-Barr Virus Infection-Reference-Cited by-同舟云学术

Human Natural Killer Cells Prevent Infectious Mononucleosis Features by Targeting Lytic Epstein-Barr Virus Infection

Published:2013-12 Issue:6 Volume:5 Page:1489-1498
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Chijioke Obinna,Müller Anne,Feederle Regina,Barros Mario Henrique M.,Krieg Carsten,Emmel Vanessa,Marcenaro Emanuela,Leung Carol S.,Antsiferova Olga,Landtwing Vanessa,Bossart Walter,Moretta Alessandro,Hassan Rocio,Boyman Onur,Niedobitek Gerald,Delecluse Henri-Jacques,Capaul Riccarda,Münz Christian

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference44 articles.

1. Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students;Balfour;J. Infect. Dis.,2013

2. Dynamics of Epstein-Barr virus DNA levels in serum during EBV-associated disease;Berger;J. Med. Virol.,2001

3. Primed antigen-specific CD4+ T cells are required for NK cell activation in vivo upon Leishmania major infection;Bihl;J. Immunol.,2010

4. Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus;Björkström;J. Exp. Med.,2011

5. Clonal origins of lymphoproliferative disease induced by Epstein-Barr virus;Brown;J. Virol.,1986

Cited by 191 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human effector CD8+ T cells with an activated and exhausted-like phenotype control tumour growth in vivo in a humanized tumour model;eBioMedicine;2024-08

2. HUMAN HERPESVIRUS EPSTEIN-BARR (EBV) AND ITS PORCINE HOMOLOGS UNVEIL THE CONSERVED MECHANISM OF RECEPTOR ENDOCYTOSIS: NEW INSIGHTS INTO VIRAL IMMUNE EVASION AND ANTIVIRAL THERAPY POTENTIAL?;Slovenian Veterinary Research;2024-06-19

3. CAR T cells outperform CAR NK cells in CAR-mediated effector functions in head-to-head comparison;Experimental Hematology & Oncology;2024-05-14

4. Altered EBV specific immune control in multiple sclerosis;Journal of Neuroimmunology;2024-05

5. ITPRIPL1 binds CD3ε to impede T cell activation and enable tumor immune evasion;Cell;2024-04